Literature DB >> 24273042

Incident herpes simplex virus type 2 infection increases the risk of subsequent episodes of bacterial vaginosis.

Linnet Masese1, Jared M Baeten, Barbra A Richardson, Elizabeth Bukusi, Grace John-Stewart, Walter Jaoko, Juma Shafi, James Kiarie, R Scott McClelland.   

Abstract

Herpes simplex virus type 2 (HSV-2) infected women have a higher prevalence of bacterial vaginosis (BV) compared to HSV-2-seronegative women. To explore the temporal association between these conditions, we evaluated the frequency of BV episodes before and after HSV-2 acquisition in a prospective study of 406 HSV-2/HIV-1-seronegative Kenyan women, of whom 164 acquired HSV-2. Incident HSV-2 was associated with increased likelihood of BV (adjusted OR, 1.28; 95% CI, 1.05-1.56; P = .01). Our findings strengthen the evidence for a causal link between genital HSV-2 infection and disruption of the vaginal microbiota.

Entities:  

Keywords:  Africa; Bacterial vaginosis; herpes simplex virus type 2; women

Mesh:

Year:  2013        PMID: 24273042      PMCID: PMC3952675          DOI: 10.1093/infdis/jit634

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Herpes simplex virus and HIV-1: deciphering viral synergy.

Authors:  Philippe Van de Perre; Michel Segondy; Vincent Foulongne; Abdoulaye Ouedraogo; Issouf Konate; Jean-Marie Huraux; Philippe Mayaud; Nicolas Nagot
Journal:  Lancet Infect Dis       Date:  2008-08       Impact factor: 25.071

2.  Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study.

Authors:  Landon Myer; Lynette Denny; Robin Telerant; Michelle de Souza; Thomas C Wright; Louise Kuhn
Journal:  J Infect Dis       Date:  2005-09-09       Impact factor: 5.226

3.  Identification of Gardnerella (Haemophilus) vaginalis.

Authors:  P Piot; E Van Dyck; P A Totten; K K Holmes
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

4.  Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization.

Authors:  Thomas L Cherpes; Melissa A Melan; Jeffrey A Kant; Lisa A Cosentino; Leslie A Meyn; Sharon L Hillier
Journal:  Clin Infect Dis       Date:  2005-03-29       Impact factor: 9.079

5.  Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

Authors:  Fujie Xu; Maya R Sternberg; Benny J Kottiri; Geraldine M McQuillan; Francis K Lee; Andre J Nahmias; Stuart M Berman; Lauri E Markowitz
Journal:  JAMA       Date:  2006-08-23       Impact factor: 56.272

6.  Molecular identification of bacteria associated with bacterial vaginosis.

Authors:  David N Fredricks; Tina L Fiedler; Jeanne M Marrazzo
Journal:  N Engl J Med       Date:  2005-11-03       Impact factor: 91.245

7.  Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries.

Authors:  Andrew Mujugira; Rhoda Ashley Morrow; Connie Celum; Jairam Lingappa; Sinead Delany-Moretlwe; Kenneth H Fife; Renee Heffron; Guy De Bruyn; Brigitte Homawoo; Etienne Karita; Nelly Mugo; Bellington Vwalika; Jared M Baeten
Journal:  Sex Transm Infect       Date:  2011-02-09       Impact factor: 3.519

8.  A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology.

Authors:  Thomas L Cherpes; Sharon L Hillier; Leslie A Meyn; James L Busch; Marijane A Krohn
Journal:  Sex Transm Dis       Date:  2008-01       Impact factor: 2.830

9.  Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora.

Authors:  Thomas L Cherpes; Leslie A Meyn; Marijane A Krohn; Sharon L Hillier
Journal:  Sex Transm Dis       Date:  2003-05       Impact factor: 2.830

10.  Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections.

Authors:  Rupert Kaul; Nico J Nagelkerke; Joshua Kimani; Elizabeth Ngugi; Job J Bwayo; Kelly S Macdonald; Anu Rebbaprgada; Karolien Fonck; Marleen Temmerman; Allan R Ronald; Stephen Moses
Journal:  J Infect Dis       Date:  2007-10-25       Impact factor: 5.226

View more
  10 in total

1.  Prevalent Herpes Simplex Virus-2 Increases the Risk of Incident Bacterial Vaginosis in Women from South Africa.

Authors:  Nathlee S Abbai; Makandwe Nyirenda; Sarita Naidoo; Gita Ramjee
Journal:  AIDS Behav       Date:  2018-07

2.  Impact of Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Dual Infection on Female Genital Tract Mucosal Immunity and the Vaginal Microbiome.

Authors:  Marla J Keller; Ashley Huber; Lilia Espinoza; Myrna G Serrano; Hardik I Parikh; Gregory A Buck; Jeremy A Gold; Yiqun Wu; Tao Wang; Betsy C Herold
Journal:  J Infect Dis       Date:  2019-07-31       Impact factor: 5.226

3.  Does bacterial vaginosis modify the effect of hormonal contraception on HIV seroconversion.

Authors:  Michelle C Sabo; Barbra A Richardson; Ludo Lavreys; Harold L Martin; Walter Jaoko; Kishorchandra Mandaliya; Jared M Baeten; Julie Overbaugh; R Scott McClelland
Journal:  AIDS       Date:  2019-06-01       Impact factor: 4.177

4.  Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012.

Authors:  Linnet Masese; Jared M Baeten; Barbra A Richardson; Elizabeth Bukusi; Grace John-Stewart; Susan M Graham; Juma Shafi; James Kiarie; Julie Overbaugh; R Scott McClelland
Journal:  AIDS       Date:  2015-06-01       Impact factor: 4.177

Review 5.  Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV.

Authors:  Richard A Cone
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

6.  Hormonal Contraception and Vaginal Infections Among Couples Who Are Human Immunodeficiency Virus Serodiscordant in Lusaka, Zambia.

Authors:  Lisa B Haddad; Kristin M Wall; Katherine Tote; William Kilembe; Bellington Vwailika; Tyronza Sharkey; Ilene Brill; Elwyn Chomba; Amanda Tichacek; Susan Allen
Journal:  Obstet Gynecol       Date:  2019-09       Impact factor: 7.623

7.  Derivation of an HIV Risk Score for African Women Who Engage in Sex Work.

Authors:  Alexandra C Willcox; Barbra A Richardson; Juma Shafi; Emmanuel Kabare; John Kinuthia; Walter Jaoko; Kishorchandra Mandaliya; Julie Overbaugh; R Scott McClelland
Journal:  AIDS Behav       Date:  2021-04-16

8.  Prevalence and incidence estimation of HSV-2 by two IgG ELISA methods among South African women at high risk of HIV.

Authors:  Irith De Baetselier; Joris Menten; Vicky Cuylaerts; Khatija Ahmed; Jennifer Deese; Lut Van Damme; Tania Crucitti
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

Review 9.  Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health.

Authors:  Mariya I Petrova; Elke Lievens; Shweta Malik; Nicole Imholz; Sarah Lebeer
Journal:  Front Physiol       Date:  2015-03-25       Impact factor: 4.566

Review 10.  Mechanisms of Immune Control of Mucosal HSV Infection: A Guide to Rational Vaccine Design.

Authors:  Naomi R Truong; Jacinta B Smith; Kerrie J Sandgren; Anthony L Cunningham
Journal:  Front Immunol       Date:  2019-03-06       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.